News

A new study being conducted by Northampton University wants your help with their new research.

The study is trying to understand more about the anomalous experiences of people with epilepsy. In previous studies on this issue, some people with epilepsy have reported experiencing déjá-vu, hallucinations, out of body experiences, the sense of a spiritual presence - amongst other unusual or irregular experiences that  they associate with their epilepsy/seizures.

Further to our recent updates regarding a European review of data on the potential risk of neurodevelopmental disorders in children conceived by fathers who are taking Sodium Valproate, we can confirm a ‘Dear Healthcare Professional’  communication has been issued by the Health Products Regulatory Authority (HPRA) to clinicians across Ireland regarding this ongoing review.

Watch the Taoiseach's opening address to delegates at #IEC2023 and read correspondence we have sent to the Taoiseach, following a State Reception to mark #IEC2023.

A new discovery by researchers in Cork could lead to new targeted treatments for Drug-resistant epilepsy.

Following a review of three recent studies, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended that a Pregnancy Prevention Programme (PPP) be introduced around the use of the Anti-Seizure Medication Topiramate (Topamax).

We will be meeting with the Minister for Social Protection in the weeks following #IEC2023.

A new international study has highlighted areas of DNA that might be involved in the development of epilepsy.

For the first time in almost 25 years, we will be moving to the future without Training for Success (TFS) as part of our service.

It’s back to school season so we wanted to remind people how Epilepsy Ireland help support you, your child, and their school with their return to the classroom and provide some important information on epilepsy and school.

First and foremost, it is recommended that any child with epilepsy who could have seizures in school has an individualised Care Plan. These plans should cover:

The EMA have provided an update on their ongoing assessment of a paper on the risks of paternal exposure to valproate.